Amarin has a critical court date against a set of defendants in January this year.
Aridis is developing a new antibody platform.
Wave Life Sciences produces mixed results.
Amarin (AMRN) is fast approaching a significant event as the company’s lawsuit against a couple of generic drug makers is scheduled for trial on January 13, 2020. The main counter parties in this